Fox Run Management, L.L.C. Biomarin Pharmaceutical Inc Transaction History
Fox Run Management, L.L.C.
- $526 Million
- Q4 2024
A detailed history of Fox Run Management, L.L.C. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 8,216 shares of BMRN stock, worth $565,342. This represents 0.1% of its overall portfolio holdings.
Number of Shares
8,216
Previous 14,366
42.81%
Holding current value
$565,342
Previous $1.01 Million
46.48%
% of portfolio
0.1%
Previous 0.23%
Shares
11 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.56 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.33 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.25 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.01 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$894 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...